bioma vs glp-1 Booster – TrustScore® 6.4/10 GLP-1 Not Working? Your Gut

The STEP clinical trial program, which evaluated semaglutide at the 2.4mg weekly dose for weight management, provides the most robust data

BPC-157 has zero FDA-approved indications for any condition

A: Side effects are rare and typically limited to mild injection site reactions such as redness or discomfort

Zeydabadi Nejad, S., Ramezani Tehrani, F., & Zadeh-Vakili, A

Bottom Line GLP-1 agonists have a place in medicine as treatment for Type 2 diabetes and obesity, offering benefits in blood sugar control and weight loss

Doctors had been giving it to their patients to relieve a host of ailments, ranging from liver disease to cancer, when they noticed that it was also making their patients skin lighter and more radiant